Skip to content
Colorectal Cancer Clinical Trials

Virginia

Colorectal cancer clinical trials in Virginia

98 colorectal cancer studies are recruiting participants at sites in 34 cities across Virginia as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Virginia city with a recruiting study

Fairfax (62), Richmond (20), Charlottesville (15), South Hill (8), Roanoke (7), Midlothian (6), Mechanicsville (5), Norfolk (5), Lynchburg (4), Arlington (3), Salem (3), Winchester (3), Woodbridge (3), Blacksburg (2), Burke (2), Chesapeake (2), Fishersville (2), Fredericksburg (2), Martinsville (2), McLean (2), Newport News (2), Virginia Beach (2), Williamsburg (2), Gloucester (1), Low Moor (1), Manassas (1), Orange (1), Petersburg (1), Portsmouth (1), Raonoke (1), Reston (1), Suffolk (1), Tappahannock (1), Wytheville (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Virginia

Basic details from each study's public record (the 12 most recently updated of 98). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Recruiting in
    Fairfax
    Registry record
    NCT06324357 · updated
  2. A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

    • Phase 1/2
    • Ages 18 to 75
    • All sexes
    Sponsor
    Tyligand Pharmaceuticals (Suzhou) Limited
    Recruiting in
    Fairfax
    Registry record
    NCT06385925 · updated
  3. A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 to 99
    • All sexes
    Sponsor
    Erasca, Inc.
    Recruiting in
    Fairfax
    Registry record
    NCT06983743 · updated
  4. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Recruiting in
    Fairfax
    Registry record
    NCT07488676 · updated
  5. A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    SOTIO Biotech a.s.
    Recruiting in
    Fairfax
    Registry record
    NCT07693751 · updated
  6. A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pliant Therapeutics, Inc.
    Recruiting in
    Fairfax
    Registry record
    NCT06270706 · updated
  7. Shield Post-Approval Study Protocol

    • Observational
    • Ages 45 to 81
    • All sexes
    Sponsor
    Guardant Health, Inc.
    Recruiting in
    Williamsburg
    Registry record
    NCT06880055 · updated
  8. A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Charlottesville · Fairfax
    Registry record
    NCT06997497 · updated
  9. A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kestrel Therapeutics, Inc.
    Recruiting in
    Fairfax
    Registry record
    NCT07458347 · updated
  10. A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Recruiting in
    Charlottesville · Fairfax
    Registry record
    NCT07659795 · updated
  11. A KRAS Inhibitor in Participants With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Ensem Therapeutics
    Recruiting in
    Fairfax
    Registry record
    NCT07912593 · updated
  12. A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Recruiting in
    Charlottesville · Fairfax
    Registry record
    NCT07020221 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Virginia on ClinicalTrials.gov.

Ask about studies in Virginia

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call